These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 17395585)

  • 1. D1 and D2 dopamine receptor expression is regulated by direct interaction with the chaperone protein calnexin.
    Free RB; Hazelwood LA; Cabrera DM; Spalding HN; Namkung Y; Rankin ML; Sibley DR
    J Biol Chem; 2007 Jul; 282(29):21285-300. PubMed ID: 17395585
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diverse pathways for maturation of the Na,K-ATPase β1 and β2 subunits in the endoplasmic reticulum of Madin-Darby canine kidney cells.
    Tokhtaeva E; Sachs G; Vagin O
    J Biol Chem; 2010 Dec; 285(50):39289-302. PubMed ID: 20937802
    [TBL] [Abstract][Full Text] [Related]  

  • 3. N-glycan in the scavenger receptor cysteine-rich domain of hepsin promotes intracellular trafficking and cell surface expression.
    Sun S; Wang L; Zhang S; Zhang C; Chen Y; Wu Q; Dong N
    Int J Biol Macromol; 2020 Oct; 161():818-827. PubMed ID: 32553951
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulation of transport of the dopamine D1 receptor by a new membrane-associated ER protein.
    Bermak JC; Li M; Bullock C; Zhou QY
    Nat Cell Biol; 2001 May; 3(5):492-8. PubMed ID: 11331877
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Folding of thyroglobulin in the calnexin/calreticulin pathway and its alteration by loss of Ca2+ from the endoplasmic reticulum.
    Di Jeso B; Ulianich L; Pacifico F; Leonardi A; Vito P; Consiglio E; Formisano S; Arvan P
    Biochem J; 2003 Mar; 370(Pt 2):449-58. PubMed ID: 12401114
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fluorescence studies reveal heterodimerization of dopamine D1 and D2 receptors in the plasma membrane.
    Dziedzicka-Wasylewska M; Faron-Górecka A; Andrecka J; Polit A; Kuśmider M; Wasylewski Z
    Biochemistry; 2006 Jul; 45(29):8751-9. PubMed ID: 16846218
    [TBL] [Abstract][Full Text] [Related]  

  • 7. N-Glycan-dependent and -independent quality control of human δ opioid receptor N-terminal variants.
    Lackman JJ; Markkanen PM; Hogue M; Bouvier M; Petäjä-Repo UE
    J Biol Chem; 2014 Jun; 289(25):17830-42. PubMed ID: 24798333
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Studies on the role of the receptor protein motifs possibly involved in electrostatic interactions on the dopamine D1 and D2 receptor oligomerization.
    Łukasiewicz S; Faron-Górecka A; Dobrucki J; Polit A; Dziedzicka-Wasylewska M
    FEBS J; 2009 Feb; 276(3):760-75. PubMed ID: 19143836
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HIV-1 protein Nef inhibits activity of ATP-binding cassette transporter A1 by targeting endoplasmic reticulum chaperone calnexin.
    Jennelle L; Hunegnaw R; Dubrovsky L; Pushkarsky T; Fitzgerald ML; Sviridov D; Popratiloff A; Brichacek B; Bukrinsky M
    J Biol Chem; 2014 Oct; 289(42):28870-84. PubMed ID: 25170080
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human delta opioid receptor biogenesis is regulated via interactions with SERCA2b and calnexin.
    Tuusa JT; Leskelä TT; Petäjä-Repo UE
    FEBS J; 2010 Jul; 277(13):2815-29. PubMed ID: 20528919
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Peptide-based interactions with calnexin target misassembled membrane proteins into endoplasmic reticulum-derived multilamellar bodies.
    Korkhov VM; Milan-Lobo L; Zuber B; Farhan H; Schmid JA; Freissmuth M; Sitte HH
    J Mol Biol; 2008 Apr; 378(2):337-52. PubMed ID: 18367207
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The subcellular distribution of calnexin is mediated by PACS-2.
    Myhill N; Lynes EM; Nanji JA; Blagoveshchenskaya AD; Fei H; Carmine Simmen K; Cooper TJ; Thomas G; Simmen T
    Mol Biol Cell; 2008 Jul; 19(7):2777-88. PubMed ID: 18417615
    [TBL] [Abstract][Full Text] [Related]  

  • 13. UBC9-dependent association between calnexin and protein tyrosine phosphatase 1B (PTP1B) at the endoplasmic reticulum.
    Lee D; Kraus A; Prins D; Groenendyk J; Aubry I; Liu WX; Li HD; Julien O; Touret N; Sykes BD; Tremblay ML; Michalak M
    J Biol Chem; 2015 Feb; 290(9):5725-38. PubMed ID: 25586181
    [TBL] [Abstract][Full Text] [Related]  

  • 14. N-Myristoyltransferase 1 interacts with calnexin at the endoplasmic reticulum.
    Dudek E; Millott R; Liu WX; Beauchamp E; Berthiaume LG; Michalak M
    Biochem Biophys Res Commun; 2015 Dec; 468(4):889-93. PubMed ID: 26603938
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A systematic search for endoplasmic reticulum (ER) membrane-associated RING finger proteins identifies Nixin/ZNRF4 as a regulator of calnexin stability and ER homeostasis.
    Neutzner A; Neutzner M; Benischke AS; Ryu SW; Frank S; Youle RJ; Karbowski M
    J Biol Chem; 2011 Mar; 286(10):8633-8643. PubMed ID: 21205830
    [TBL] [Abstract][Full Text] [Related]  

  • 16. N-Glycan-calnexin interactions in human factor VII secretion and deficiency.
    Wang H; Wang L; Li S; Dong N; Wu Q
    Int J Biochem Cell Biol; 2019 Aug; 113():67-74. PubMed ID: 31185295
    [TBL] [Abstract][Full Text] [Related]  

  • 17. N-Glycan-based ER Molecular Chaperone and Protein Quality Control System: The Calnexin Binding Cycle.
    Lamriben L; Graham JB; Adams BM; Hebert DN
    Traffic; 2016 Apr; 17(4):308-26. PubMed ID: 26676362
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fatty acid binding protein (Fabp) 5 interacts with the calnexin cytoplasmic domain at the endoplasmic reticulum.
    Jung J; Wang J; Groenendyk J; Lee D; Michalak M; Agellon LB
    Biochem Biophys Res Commun; 2017 Nov; 493(1):202-206. PubMed ID: 28911862
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glycan-independent role of calnexin in the intracellular retention of Charcot-Marie-tooth 1A Gas3/PMP22 mutants.
    Fontanini A; Chies R; Snapp EL; Ferrarini M; Fabrizi GM; Brancolini C
    J Biol Chem; 2005 Jan; 280(3):2378-87. PubMed ID: 15537650
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rer1 and calnexin regulate endoplasmic reticulum retention of a peripheral myelin protein 22 mutant that causes type 1A Charcot-Marie-Tooth disease.
    Hara T; Hashimoto Y; Akuzawa T; Hirai R; Kobayashi H; Sato K
    Sci Rep; 2014 Nov; 4():6992. PubMed ID: 25385046
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.